期刊文献+

内皮抑制素相互作用蛋白HT036基因的全长克隆及其促血管上皮细胞凋亡的分子机制

Full-length clone of protein HT036 gene interacting with endostatin and its molecular mechanism in promoting the apoptosis of vascular endothelial cell
下载PDF
导出
摘要 目的:克隆与内皮抑制素(endostatin)相互作用蛋白HT036基因的全长,进一步验证其与内皮抑制素的相互作用,初步阐明其促血管上皮细胞凋亡的分子机制。方法:实验于2004-10/2006-03在解放军总医院呼吸科实验室、军事医学科学院放射医学和生物工程研究所实验室完成。①根据已知HT036的EST序列设计引物,应用RACE技术,从人胎肝cDNA文库获取该基因全长。②采用免疫共沉淀和WesternBlot验证HT036蛋白与内皮抑制素在真核细胞内存在相互作用。③利用真核瞬时表达载体pCDNA3.1(+)在EVC304细胞中瞬时表达HT036蛋白,转染了HT036基因的EVC304细胞为试验组(重复两次);没有转染HT036基因的细胞为对照组,用流式细胞仪检测HT036基因对细胞凋亡和细胞周期的影响。结果:①HT036基因全长克隆及生物信息学分析结果:利用RACE技术成功获得HT036基因的全长,并在GENEBANK进行了注册,注册号AY775560。②免疫共沉淀和Western-blot的验证结果:证实HT036蛋白能与内皮抑制素在真核细胞中相互作用。③HT036基因对细胞凋亡和细胞周期的影响:成功构建了表达HT036基因的真核表达载体,两次试验转染ECV304细胞后24h的凋亡率平均为23.63%,而对照组仅为0.10%。结论:获得了一与内皮抑制素相互作用的新的蛋白HT036基因的全长,初步表明HT036参与了内皮抑制素调节的血管生成过程,并对血管上皮细胞具有促进凋亡的作用。 AIM: To clone the full length of protein gene HT036 interacts with endostatin, and further identify the interaction between them and elucidate the molecular mechanism of HT036 gene in promoting the apoptosis of vascular endothelial cells. METHODS: The experiment was conducted in the Laboratory of Respiration of General Hospital of Chinese PLA and the Laboratory of Radiology and Bioengineering of Academy of Military Medical Sciences between October 2004 and March 2006, (1) RACE was used to clone the full length of HT036 gene from human liver cDNA library based on its known EST sequence. (2) Co-immunoprecipitation technology and Western Blot were adopted to identify the interaction between HT036 protein and endostatin in eucaryotic cell. (3) The eucaryotic transient expression vector pCDNA3.1 (+) which expressed HT036 protein was constructed and transferred into EVC304 cells. The EVC304 cells being transferred into HT036 were taken as the experiment group (repeated twice), and EVC30-4 cells without transfection were taken as the control group. Flow cytometry was used to detect the effect of HT036 gene on cell apoptosis and cell cycles. RESULTS: (1) Analysis of the full length of HT036 gene clone and its bioinformatics: The full length of HT036 was successfully cloned and registered into Genebank with the number of AY775560. (2) Co-immunoprecipitation and Western-blot proved that HT036 protein could interact with endothelial protein in COS-7 cells. (3) Effect of HT036 on cell apoptosis and cell cycle: HT036 gene was successfully inserted into pCDNA3.1 vector and transferred into cell EVC304 twice with an average apoptotic rate of 23.63% at 24 hours after transfection, while that in the control group was just 0.10%. CONCLUSION: The full length of HT036 gene that interact with the endostatin is obtained, and it is primarily manifested that HT036 participates in the vascularization which is regulated by endostain and can promote the apoptosis of vascular endothelial c
出处 《中国临床康复》 CSCD 北大核心 2006年第41期66-68,共3页 Chinese Journal of Clinical Rehabilitation
基金 国家自然科学基金(30300404 30400198 北京市自然科学基金资助项目(7042057)~~
  • 相关文献

参考文献7

  • 1Liekens S,Clercq ED,Neyts J.Angiogenesis:regulators and clinical applications.Biochem Pharm 2001;61:253-70 被引量:1
  • 2Rehn M,Pihlajaniemi T.Alpha 1 (ⅩⅤⅢ),a collagen chain with frequent interruptions in the collagenous sequence,a distinct tissue distribution,and homology with type ⅩⅤ collagen.Proc Natl Acad Sci USA 1994;91:4234 被引量:1
  • 3Maucel HJ,Hanna NN,Beckett MA,et al.Combined effects of angiostatin and ionizing radiation in antitumor therapy.Nature 1998;394:287 被引量:1
  • 4张宝林,范保星,贾向旭,苑晓玲,冯怡,彭善云,马良,刘又宁.与内皮抑制素相互作用的蛋白及其抑制血管生成作用的分子机制[J].中国临床康复,2005,9(38):23-25. 被引量:1
  • 5李峰,杨芳,肖志强,陈主初.临床蛋白质组学——蛋白质组学在临床研究中的应用[J].生物化学与生物物理进展,2006,33(1):5-9. 被引量:7
  • 6Allen JB,Walberg MW,Edwards MC,et al.Finding prospective partners in the library:the two-hybrid system and phage display find a match.Trends Biochem Sci 1995;20(12):511-6 被引量:1
  • 7Gietz RD,Triggs-Raine B,Robbins A,et al.Identification of proteins that interact with a protein of interest:applications of the yeast two-hybrid system.Mol Cell Biochem 1997;172(1-2):67-79 被引量:1

二级参考文献33

  • 1Hanash S. HUPO initiatives relevant to clinical proteomics. Mol Cell Proteomics, 2004, 3 (4): 298-301. 被引量:1
  • 2Johann D J, Jr., McGuigan M D, Patel A R, et cd. Clinical proteomics and biomarker discovery. Ann N Y Acad Sci, 2004, 1022:295-305. 被引量:1
  • 3Wultkuhle J D, Liotta L A, Petricoin E F. Proteomic applications for the early detection of cancer. Nat Rev Cancer, 2003, 3 (4): 267-275. 被引量:1
  • 4Rai A J, Zhang Z, Rosenzweig J, et ol. Proteomic approaches to tumor marker discovery. Arch Pathol Lab Med, 2002, 126(12):1518-1526. 被引量:1
  • 5Zhang Z, Bast R C, Jr., Yu Y, et ol. Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res, 2004, 64 (16): 5882-5890. 被引量:1
  • 6Colantonio D A, Chan D W. The clinical application of proteomics.Clin Chim Acta, 2005, 357 (2): 151 - 158. 被引量:1
  • 7Rai A J, Gelfand C A, Haywood B C, et cd. HUPO Plasma Proteome Project specimen collection and handling: Towards the standardization of parameters for plasma proteome samples.Proteomics, 2005, 5(13): 3262-3277. 被引量:1
  • 8White C N, Chan D W, Zhang Z. Bioinformatics strategies forproteomic profiling. Clin Biochem, 2004, 37 (7): 636-641. 被引量:1
  • 9Emmert-Buck M R, Bonner R F, Smith P D, et al. Laser capture microdissection. Science, 1996, 274 (5289): 998 - 1001. 被引量:1
  • 10Liotta L A, Ferrari M, Petdcoin E. Clinical proteomics: written in blood. Nature, 2003, 425 (6961): 905. 被引量:1

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部